Tags:BioTechDesignDevelopmentHealthTechnologyUniversity
Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational design of more effective live attenuated vaccines. The technology is exclusively licensed from Emory University and Children’s Healthcare of Atlanta. Dr. Moore, together with Dr. Roderick Tang, a vaccine biotech expert, co-founded Meissa. They are supported by a team with extensive experience in all aspects of vaccine development. Meissa is currently a resident company at the Johnson & Johnson Innovation – JLABS in South San Francisco.
Location: United States, California, Redwood City
Member count: 11-50
Total raised: $33.4M
Founded date: 2014

Investors 1

DateNameWebsite
-FundRxfundrx.com

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
27.09.2019Series A$30M-vcnewsdail...
28.03.2019-$3.4M-finsmes.co...

Mentions in press and media 12

DateTitleDescriptionCategoryAuthorSource
28.10.2021A nasal CO...Meissa is developing a nasal v...--businessin...
19.07.2021Meissa Vac...In the landscape of mostly inj...--medcitynew...
27.09.2019Meissa Vac...Meissa Vaccines, a South San F...USA-finsmes.co...
27.09.2019Meissa Vac... SOUTH SAN FRANCISCO, CA, Mei...--vcnewsdail...
26.09.2019Meissa rai...Meissa Vaccines has raised $30...Biotech-fiercebiot...
28.03.2019Meissa Vac...Meissa Vaccines, a South San F...USA-finsmes.co...
07.08.2017Term Sheet...STUPID AMOUNTS OF MONEY Good ...--fortune.co...
06.08.2017FundRx bac...Meissa Vaccines, a start-up bi...--citybizlis...
03.08.2017Meissa Vac...Meissa Vaccines, a South San F...USA-finsmes.co...
-Meissa Ann...REDWOOD CITY, Calif.--(BUSINES...--oaoa.com/n...
Show more